Up | AC
Home Page
Food and
Drug Administration
Transmissible Spongiform Ensephalopathies Advisory Committee
Additional Briefing Information
Topic I continuation: Questions and Answers on vCJD and pdFVIII (htm) (pdf)
Topic I continuation: Potential vCJD Risk from US Licensed Plasma-Derived Factor VIII (PDFVIII, Antihemophilic Factor) Products: Summary Information (htm) (pdf)